392 related articles for article (PubMed ID: 35363853)
21. Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications.
Jolly MK; Murphy RJ; Bhatia S; Whitfield HJ; Redfern A; Davis MJ; Thompson EW
Cells Tissues Organs; 2022; 211(2):110-133. PubMed ID: 33902034
[TBL] [Abstract][Full Text] [Related]
22. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
24. Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells.
He P; Qiu K; Jia Y
Sci Rep; 2018 Sep; 8(1):14323. PubMed ID: 30254295
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: Shifting gears at the molecular level.
Basu B; Ghosh MK
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119261. PubMed ID: 35307468
[TBL] [Abstract][Full Text] [Related]
26. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
27. EMT and MET: necessary or permissive for metastasis?
Jolly MK; Ware KE; Gilja S; Somarelli JA; Levine H
Mol Oncol; 2017 Jul; 11(7):755-769. PubMed ID: 28548345
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
[TBL] [Abstract][Full Text] [Related]
29. A specialist-generalist framework for epithelial-mesenchymal plasticity in cancer.
Cook DP; Wrana JL
Trends Cancer; 2022 May; 8(5):358-368. PubMed ID: 35183479
[TBL] [Abstract][Full Text] [Related]
30. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response.
Jia D; Li X; Bocci F; Tripathi S; Deng Y; Jolly MK; Onuchic JN; Levine H
J Clin Med; 2019 May; 8(5):. PubMed ID: 31121840
[TBL] [Abstract][Full Text] [Related]
31. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.
Romeo E; Caserta CA; Rumio C; Marcucci F
Cells; 2019 May; 8(5):. PubMed ID: 31096701
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis.
Plygawko AT; Kan S; Campbell K
Philos Trans R Soc Lond B Biol Sci; 2020 Oct; 375(1809):20200087. PubMed ID: 32829692
[TBL] [Abstract][Full Text] [Related]
33. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring.
Bhatia S; Monkman J; Toh AKL; Nagaraj SH; Thompson EW
Biochem J; 2017 Sep; 474(19):3269-3306. PubMed ID: 28931648
[TBL] [Abstract][Full Text] [Related]
34. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
Liao TT; Yang MH
Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
[TBL] [Abstract][Full Text] [Related]
35. Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition.
Sinha A; Mehta P; Fan C; Zhang J; Marvin DL; van Dinther M; Ritsma L; Boukany PE; Ten Dijke P
Methods Mol Biol; 2022; 2488():47-65. PubMed ID: 35347682
[TBL] [Abstract][Full Text] [Related]
36. Intermediate cell states in epithelial-to-mesenchymal transition.
Sha Y; Haensel D; Gutierrez G; Du H; Dai X; Nie Q
Phys Biol; 2019 Jan; 16(2):021001. PubMed ID: 30560804
[TBL] [Abstract][Full Text] [Related]
37. Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.
Calabrò ML; Lazzari N; Rigotto G; Tonello M; Sommariva A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266161
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
39. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.
Dongre A; Weinberg RA
Nat Rev Mol Cell Biol; 2019 Feb; 20(2):69-84. PubMed ID: 30459476
[TBL] [Abstract][Full Text] [Related]
40. The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression.
Abaurrea A; Araujo AM; Caffarel MM
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
